Hybrid Cell Vaccination in Patients With Metastatic Melanoma
Hybrid cell vaccination is a novel approach for immunotherapy of cancers by inducing specific antitumor immunity (1 ,2). The hybrid cells are generated by electrofusing autologous tumor cells with allogeneic MHC class II expressing cells such as B lymphocytes. The fused cells are irradiated and injected subcutaneously as a vaccine. This immune therapeutical approach aims at recruitment of T-cell help for the induction of tumor-specific cytolytic immunity. It is based on the observation that epitope linkage is a prerequisite for productive T-T cell collaboration, i.e., cytolytic precursor and helper T cells have to be activated by the same antigen presenting cell that displays epitopes for both T-cell types on the corresponding MHC class I and class II molecules (3 ,4). Neither of the two epitopes nor the corresponding T cells need to be related. The implications of this concept are, first, only MHC class I and II expressing cells can induce cytolytic T-cell responses (5 -7), second, cognate antigens must be presented for both T-cell and MHC types (4 ,8) and, third, there must be T cells with the corresponding specificities in the T-cell receptor repertoire of the response-competent individual.
KeywordsHybrid Cell Glucose Solution Autologous Tumor Cell Fusion Efficiency Autologous Melanoma Cell
- 3.Mitchison, N. A., Rajewski, K., and Taylor, R. B. (1970) Cooperation of antigenic determinants of cells in the induction of antibodies, in Developmental Aspects of Antibody Formation and Structure (Sterzl, J. and Riha, I., eds.), Academic, New York, pp. 547–547.Google Scholar
- 4.Mitchison, N. A. and O’Malley, C. (1987) Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in-vivo cytolytic response. Eur. J. Immunol. 17, 1479–1483.Google Scholar
- 9.Trefzer, U., Weingart, G., Chen, Y., Adrian, K., Audring, H., Winter, H., et al. (1998) A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma, in Proc. 3rd Europ. Conf. Gene Ther. 1997 (P. Walden, U. Trefzer, W. Sterry, and Farzaneh, F., eds.), Plenum, London, pp. 519–525.Google Scholar
- 11.Neil, G. A and Zimmermann, U. (1993) Electrofusion, in Methods in Enzymology (Moldave, K. and Grossman, L., eds.). Academic, New York, pp. 174–196.Google Scholar